Phase I results of exicorilant plus enzalutamide in patients with castration-resistant prostate cancer Meeting Abstract


Authors: Linch, M.; Liu, G.; Crabb, S. J.; Beer, T. M.; Heath, E.; Gordon, M.; de Bono, J. S.; Pashova, H. I.; Tudor, I. C.; Custodio, J. M.; Mann, G.; Morris, M. J.
Abstract Title: Phase I results of exicorilant plus enzalutamide in patients with castration-resistant prostate cancer
Meeting Title: ESMO Congress 2022
Journal Title: Annals of Oncology
Volume: 33
Issue: Suppl. 7
Meeting Dates: 2022 Sep 9-13
Meeting Location: Paris, France
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2022-09-01
Start Page: S1183
Language: English
ACCESSION: WOS:000866211601654
PROVIDER: wos
DOI: 10.1016/j.annonc.2022.07.1883
Notes: Meeting Abstract: 1397P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    577 Morris